Autologous bone marrow-derived stem cell (University of Kentucky)

N/A

Report date: 2023/01/07 17:45:22

Base Information

Drug NameAutologous bone marrow-derived stem cell (University of Kentucky)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsMyocardial Ischemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Kentucky
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Kentucky
Inactive CompaniesN/A
Active IndicationsMyocardial Ischemia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A